Salvia miltiorrhiza inhibits intimal hyperplasia and monocyte chemotactic protein-1 expression after balloon injury in cholesterol-fed rabbits.
Antioxidants that prevent low density lipoproteins (LDL) from oxidation may inhibit atherosclerosis and post-angioplasty restenosis. Salvia miltiorrhiza (SM) has been shown to inhibit LDL oxidation and reduce atherosclerosis in cholesterol-fed rabbits. The effects of SM on neointimal hyperplasia and monocyte chemotactic protein-1 (MCP-1) expression after balloon injury were studied. Male New Zealand white rabbits were fed a 2% cholesterol diet together with daily SM (4.8 gm/kg body wt.) treatment (SM; n=10) or without SM as a control (C; n=9) for 6 weeks. Probucol-treated (0.6 gm/kg body wt.) rabbits (P; n=9) were used as a positive control group. A balloon injury of the abdominal aorta was performed at the end of the third week. Aortas were harvested at the end of 6 weeks. The plasma cholesterol levels were lowered in SM group. The neointimal hyperplasia in abdominal aortas was significantly inhibited in SM group [neointima/media area ratio: 0.63+/-0.05 (SM) versus 0.78+/-0.05 (C); P < 0.05] and in P group [0.45+/-0.02 (P) versus 0.78+/-0.05 (C); P < 0.05] when compared with C group. SM treatment significantly reduced MCP-1 mRNA and protein expression in balloon-injured abdominal aorta. These inhibitory effects on intimal response after balloon injury might be attributed to antioxidant capacity and cholesterol lowering effect of SM. SM treatment may offer some protection against post-angioplasty restenosis.
Chen
Y L
YL
Institute of Anatomy and Cell Biology, National Yang-Ming University, Taipei, Taiwan.
Yang
S P
SP
Shiao
M S
MS
Chen
J W
JW
Lin
S J
SJ
D000800:Angioplasty, Balloon / Q000009:adverse effects; D000818:Animals; D001161:Arteriosclerosis / Q000628:therapy; D015152:Blotting, Northern; D018932:Chemokine CCL2 / Q000096:biosynthesis*; D002784:Cholesterol / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D023903:Coronary Restenosis; D006965:Hyperplasia / Q000188:drug therapy*; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008077:Lipoproteins, LDL / Q000378:metabolism; D008297:Male; D010100:Oxygen / Q000378:metabolism; D010936:Plant Extracts / Q000627:therapeutic use*; D012313:RNA / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D011817:Rabbits; D027561:Salvia miltiorrhiza / Q000378:metabolism*; D013997:Time Factors; D017539:Tunica Intima / Q000473:pathology*
D018932:Chemokine CCL2; D008077:Lipoproteins, LDL; D010936:Plant Extracts; D012333:RNA, Messenger; D012313:RNA; D002784:Cholesterol; D010100:Oxygen